Business · 03/01/2017
FDA Releases Draft Guidance on Labeling Red Blood Cell Units with Historical Antigen Typing Results
The US Food and Drug Administration (FDA) has made available a draft document outlining recommendations for labeling Red Blood Cell (RBC) units with historical antigen typing results, which will help transfusion services manage these units and comply with biologics regulations.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →